In this video, Dr. Upendra Kaul, Executive Director & Dean, Fortis Group of Hospitals, will talk that India's private sector or Government does not have a policy on venturing into the stent market in India. He says that things are changing rapidly. The first generations of the cardiovascular devices started from the west as they had the patents. Also, the research and development of such devices take lot of money. Stents in India came during 1989 – 90. There is always a competition regarding good quality or parameters are compared. He further says that one third of the stents used in the country are from Indian market.
Chairman Batra Heart Centre and Dean Academics and Research of BHMRC, New Delhi.
Dr. Upendra Kaul is currently Chairman Batra Heart Centre and Dean Academics and Research of BHMRC, New Delhi. He was formerly Professor of Cardiology at All India Institute of Medical Sciences, New Delhi. He has also been on the faculty of G.B. Pant Hospital, New Delhi, PGIMER, Chandigarh and Batra Hospital, New Delhi. Prof. Kaul is one of the first Cardiologists to start coronary interventions in India. He has started a number of new techniques in Interventional Cardiology which include percutaneous cardiopulmonary bypass, rotational & directional atherectomy, coronary stenting and percutaneous laser myocardial revascularization etc. He has trained more than 200 full time cardiologists and is on the faculty of several prestigious universities in USA, Europe, Far East, China & Australia. He also participates as a faculty in most of the important meetings in Interventional Cardiology nationally and internationally. Prof. Kaul is a Past President of the Cardiological Society of India & is currently Vice President of the SAARC Cardiac Society. Dr. Kaul has been a recipient of several prestigious awards such as the Dr B C Roy Award for developing specialties in 1999 and the Padmashri in 2006.
Webinar on Therapeutic Goals of COVID-19
These novel ESC/EAS Guidelines on lipids provide important new advice on patient managemen